254 related articles for article (PubMed ID: 31500118)
1. Oxidation of Human Copper Chaperone Atox1 and Disulfide Bond Cleavage by Cisplatin and Glutathione.
Nardella MI; Rosato A; Belviso BD; Caliandro R; Natile G; Arnesano F
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31500118
[TBL] [Abstract][Full Text] [Related]
2. Redox sulfur chemistry of the copper chaperone Atox1 is regulated by the enzyme glutaredoxin 1, the reduction potential of the glutathione couple GSSG/2GSH and the availability of Cu(I).
Brose J; La Fontaine S; Wedd AG; Xiao Z
Metallomics; 2014 Apr; 6(4):793-808. PubMed ID: 24522867
[TBL] [Abstract][Full Text] [Related]
3. Binding of Copper and Cisplatin to Atox1 Is Mediated by Glutathione through the Formation of Metal-Sulfur Clusters.
Dolgova NV; Yu C; Cvitkovic JP; Hodak M; Nienaber KH; Summers KL; Cotelesage JJH; Bernholc J; Kaminski GA; Pickering IJ; George GN; Dmitriev OY
Biochemistry; 2017 Jun; 56(24):3129-3141. PubMed ID: 28549213
[TBL] [Abstract][Full Text] [Related]
4. Mechanistic and Structural Basis for Inhibition of Copper Trafficking by Platinum Anticancer Drugs.
Lasorsa A; Nardella MI; Rosato A; Mirabelli V; Caliandro R; Caliandro R; Natile G; Arnesano F
J Am Chem Soc; 2019 Jul; 141(30):12109-12120. PubMed ID: 31283225
[TBL] [Abstract][Full Text] [Related]
5. Functional partnership of the copper export machinery and glutathione balance in human cells.
Hatori Y; Clasen S; Hasan NM; Barry AN; Lutsenko S
J Biol Chem; 2012 Aug; 287(32):26678-87. PubMed ID: 22648419
[TBL] [Abstract][Full Text] [Related]
6. Determinants for simultaneous binding of copper and platinum to human chaperone Atox1: hitchhiking not hijacking.
Palm-Espling ME; Andersson CD; Björn E; Linusson A; Wittung-Stafshede P
PLoS One; 2013; 8(7):e70473. PubMed ID: 23936210
[TBL] [Abstract][Full Text] [Related]
7. Cisplatin binds human copper chaperone Atox1 and promotes unfolding in vitro.
Palm ME; Weise CF; Lundin C; Wingsle G; Nygren Y; Björn E; Naredi P; Wolf-Watz M; Wittung-Stafshede P
Proc Natl Acad Sci U S A; 2011 Apr; 108(17):6951-6. PubMed ID: 21482801
[TBL] [Abstract][Full Text] [Related]
8. Thiol-based copper handling by the copper chaperone Atox1.
Hatori Y; Inouye S; Akagi R
IUBMB Life; 2017 Apr; 69(4):246-254. PubMed ID: 28294521
[TBL] [Abstract][Full Text] [Related]
9. Memo1 binds reduced copper ions, interacts with copper chaperone Atox1, and protects against copper-mediated redox activity in vitro.
Zhang X; Walke GR; Horvath I; Kumar R; Blockhuys S; Holgersson S; Walton PH; Wittung-Stafshede P
Proc Natl Acad Sci U S A; 2022 Sep; 119(37):e2206905119. PubMed ID: 36067318
[TBL] [Abstract][Full Text] [Related]
10. Structural biology of cisplatin complexes with cellular targets: the adduct with human copper chaperone atox1 in aqueous solution.
Calandrini V; Nguyen TH; Arnesano F; Galliani A; Ippoliti E; Carloni P; Natile G
Chemistry; 2014 Sep; 20(37):11719-25. PubMed ID: 25111319
[TBL] [Abstract][Full Text] [Related]
11. Interaction of cisplatin and analogue Pt(en)Cl2 with the copper metallo-chaperone Atox1.
Sze CM; Shi Z; Khairallah GN; Feketeová L; O'Hair RA; Xiao Z; Donnelly PS; Wedd AG
Metallomics; 2013 Aug; 5(8):946-54. PubMed ID: 23778981
[TBL] [Abstract][Full Text] [Related]
12. Copper binding modulates the platination of human copper chaperone Atox1 by antitumor trans-platinum complexes.
Xi Z; Guo W; Tian C; Wang F; Liu Y
Metallomics; 2014 Mar; 6(3):491-7. PubMed ID: 24469739
[TBL] [Abstract][Full Text] [Related]
13. An expanding range of functions for the copper chaperone/antioxidant protein Atox1.
Hatori Y; Lutsenko S
Antioxid Redox Signal; 2013 Sep; 19(9):945-57. PubMed ID: 23249252
[TBL] [Abstract][Full Text] [Related]
14. Identification of New Potential Interaction Partners for Human Cytoplasmic Copper Chaperone Atox1: Roles in Gene Regulation?
Öhrvik H; Wittung-Stafshede P
Int J Mol Sci; 2015 Jul; 16(8):16728-39. PubMed ID: 26213915
[TBL] [Abstract][Full Text] [Related]
15. Cisplatin handover between copper transporters: the effect of reducing agents.
Galliani A; Losacco M; Lasorsa A; Natile G; Arnesano F
J Biol Inorg Chem; 2014 Jun; 19(4-5):705-14. PubMed ID: 24789146
[TBL] [Abstract][Full Text] [Related]
16. Tetrathiomolybdate inhibits the reaction of cisplatin with human copper chaperone Atox1.
Tian Y; Fang T; Yuan S; Zheng Y; Arnesano F; Natile G; Liu Y
Metallomics; 2018 May; 10(5):745-750. PubMed ID: 29721562
[TBL] [Abstract][Full Text] [Related]
17. Oxaliplatin Binding to Human Copper Chaperone Atox1 and Protein Dimerization.
Belviso BD; Galliani A; Lasorsa A; Mirabelli V; Caliandro R; Arnesano F; Natile G
Inorg Chem; 2016 Jul; 55(13):6563-73. PubMed ID: 27305454
[TBL] [Abstract][Full Text] [Related]
18. Crystal structures of cisplatin bound to a human copper chaperone.
Boal AK; Rosenzweig AC
J Am Chem Soc; 2009 Oct; 131(40):14196-7. PubMed ID: 19807176
[TBL] [Abstract][Full Text] [Related]
19. Cu(I) Controls Conformational States in Human Atox1 Metallochaperone: An EPR and Multiscale Simulation Study.
Perkal O; Qasem Z; Turgeman M; Schwartz R; Gevorkyan-Airapetov L; Pavlin M; Magistrato A; Major DT; Ruthstein S
J Phys Chem B; 2020 Jun; 124(22):4399-4411. PubMed ID: 32396355
[TBL] [Abstract][Full Text] [Related]
20. Copper chaperone Atox1 interacts with the metal-binding domain of Wilson's disease protein in cisplatin detoxification.
Dolgova NV; Nokhrin S; Yu CH; George GN; Dmitriev OY
Biochem J; 2013 Aug; 454(1):147-56. PubMed ID: 23751120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
